Last reviewed · How we verify
Severe hereditary factor VIII deficiency disease
Approved treatments
- Roctavian · BioMarin International Limited
Roctavian introduces a functional copy of the F8 gene into cells to produce factor VIII protein.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Severe hereditary factor VIII deficiency disease patent landscape — cliff calendar, originator estates, attackable patents
- Severe hereditary factor VIII deficiency disease treatment landscape brief
- Severe hereditary factor VIII deficiency disease treatment updates RSS
Frequently asked questions about Severe hereditary factor VIII deficiency disease
What drugs treat Severe hereditary factor VIII deficiency disease?
Tracked treatments include Roctavian.
What is the treatment for Severe hereditary factor VIII deficiency disease?
Standard treatment for Severe hereditary factor VIII deficiency disease includes Roctavian. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Severe hereditary factor VIII deficiency disease patent cliff · Severe hereditary factor VIII deficiency disease CI report
- Treatment: Roctavian · BioMarin International Limited
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing